CD19‐CAR engineered NK‐92 cells are sufficient to overcome NK cell resistance in B‐cell malignancies

Many B‐cell acute and chronic leukaemias tend to be resistant to killing by natural killer (NK) cells. The introduction of chimeric antigen receptors (CAR) into T cells or NK cells could potentially overcome this resistance. Here, we extend our previous observations on the resistance of malignant ly...

Descripción completa

Detalles Bibliográficos
Autores principales: Romanski, Annette, Uherek, Christoph, Bug, Gesine, Seifried, Erhard, Klingemann, Hans, Wels, Winfried S., Ottmann, Oliver G., Tonn, Torsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929308/
https://www.ncbi.nlm.nih.gov/pubmed/27008316
http://dx.doi.org/10.1111/jcmm.12810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929308/
https://www.ncbi.nlm.nih.gov/pubmed/27008316
http://dx.doi.org/10.1111/jcmm.12810

Ejemplares similares